Young Pipe Insulation and Asbestos: Manufacturer Reference

Company History

Young was a manufacturer operating in the United States whose pipe insulation products appeared on American industrial and commercial jobsites during the mid-to-late twentieth century. According to asbestos litigation records, the company was active during a period when asbestos-containing thermal insulation materials were standard across the construction and industrial trades. Specific details regarding the company’s founding date, corporate ownership history, and the precise scope of its manufacturing operations have not been conclusively established in publicly available records, though court filings document the company’s presence as a named party in asbestos-related personal injury litigation.

The decades spanning roughly the 1940s through the early 1980s represented the height of asbestos use in American manufacturing, particularly in products designed to insulate pipes carrying steam, hot water, and other high-temperature materials in industrial facilities, power plants, shipyards, and commercial construction. Young’s products were used during this era, and plaintiffs alleged that the company manufactured and distributed pipe insulation containing asbestos fiber. Like many insulation manufacturers of the period, Young is understood to have ceased asbestos use around the early 1980s, coinciding with increasing regulatory pressure from the Environmental Protection Agency and the Occupational Safety and Health Administration.

Asbestos-Containing Products

According to asbestos litigation records, Young manufactured pipe insulation products that plaintiffs alleged contained asbestos as a primary component. Asbestos — most commonly chrysotile, amosite, or crocidolite fiber types — was widely incorporated into pipe insulation during this period because of its exceptional thermal resistance, durability, and low cost. Court filings document that workers in a variety of trades encountered Young-branded pipe insulation on the job, though the precise product names, formulations, and documented asbestos percentages associated with Young’s line have not been publicly disclosed in the same detail available for some larger, better-documented manufacturers.

Pipe insulation of the type plaintiffs alleged Young produced typically consisted of preformed sectional pipe covering — rigid or semi-rigid molded sections designed to fit around pipes of standardized diameters — as well as insulating cements and finishing materials applied over the sections by hand. In the industry at large, asbestos content in such products commonly ranged from approximately 15 percent to 85 percent by weight depending on the product type and manufacturer, though no specific verified percentage has been publicly attributed to Young’s products through available regulatory or litigation records reviewed for this article.

These products were sold to contractors, industrial facilities, and distributors, and court filings document their presence across a range of jobsite types including refineries, power generation facilities, manufacturing plants, and large commercial construction projects where extensive pipe systems required thermal insulation.

Occupational Exposure

Workers in several skilled trades faced potential exposure to asbestos-containing pipe insulation during the decades when these products were in use. Plaintiffs alleged in litigation involving Young that workers who installed, repaired, removed, or worked in proximity to pipe insulation bearing the Young name sustained asbestos fiber inhalation as a result of those activities.

Pipe coverers and insulators bore the most direct contact with these products. Their work involved cutting sectional pipe covering to length using saws or knives, fitting sections around pipe systems, and applying finishing coats of insulating cement — all tasks that, according to asbestos litigation records, generated respirable asbestos dust when performed with asbestos-containing materials.

Pipefitters and steamfitters frequently worked alongside insulators during both new construction and maintenance shutdowns, and court filings document allegations that these tradespeople were exposed to asbestos dust generated by nearby insulation work even when they were not directly handling the materials themselves.

Maintenance workers and boilermakers encountered pipe insulation during repair and overhaul work at industrial facilities. Disturbing aged, damaged, or friable insulation — which asbestos-containing pipe covering becomes over time — releases fiber concentrations that plaintiffs alleged caused mesothelioma, asbestosis, and lung cancer diagnoses in exposed workers years or decades after the exposure occurred.

Laborers and helpers who assisted on jobsites where pipe insulation was being installed or removed also appear in litigation records as members of the workforce who allegedly sustained asbestos exposure through ambient dust conditions on active worksites.

The latency period for asbestos-related disease — frequently twenty to fifty years between first exposure and clinical diagnosis — means that workers exposed to Young pipe insulation products during the 1950s, 1960s, and 1970s may only now be receiving diagnoses of mesothelioma, asbestosis, or asbestos-related lung cancer. Family members of workers who carried asbestos dust home on their clothing and skin may also have sustained secondary or para-occupational exposure, and such claims have been documented in asbestos litigation records more broadly.

Specific jobsite types documented in asbestos litigation records where pipe insulation of this category appeared include:

  • Oil refineries and petrochemical plants, where extensive steam and process piping required continuous insulation coverage
  • Electric power generating stations, where high-pressure steam lines ran throughout turbine halls and boiler rooms
  • Industrial manufacturing facilities, including steel mills, paper mills, and chemical plants
  • Naval shipyards and commercial shipyards, where pipe systems ran throughout vessel interiors in confined spaces
  • Large commercial and institutional construction, including hospitals, universities, and government buildings constructed during the postwar building boom

Young falls within the category of asbestos defendants who have faced personal injury litigation without the establishment of a dedicated asbestos bankruptcy trust fund, to the extent documented in publicly available records reviewed for this article. According to asbestos litigation records, claims involving Young-branded pipe insulation have been pursued through the civil court system, with plaintiffs alleging that exposure to the company’s asbestos-containing products caused serious and often fatal disease.

Court filings document that plaintiffs alleged Young knew or should have known about the hazards associated with asbestos inhalation during the period when its products were manufactured and distributed. The question of what individual manufacturers knew about asbestos health risks — and when — has been a central issue in asbestos litigation nationally. Medical and industrial hygiene literature documenting the association between asbestos fiber inhalation and pulmonary disease dates to the 1930s and was well established within relevant industries by the 1950s and 1960s.

Because Young does not appear to be associated with a funded asbestos bankruptcy trust, individuals who believe they were exposed to Young pipe insulation and who have received a qualifying asbestos-related diagnosis may need to pursue their claims through direct litigation rather than through a trust claim process. The legal landscape for such claims varies depending on the current legal status of the company, the jurisdiction in which the claim is filed, and the specific facts of the exposure history documented.

Individuals who worked with or around Young pipe insulation should document their exposure history as completely as possible, including approximate dates of work, jobsite locations, the tasks performed in connection with the insulation materials, and the names of coworkers or supervisors who may be able to corroborate the exposure. Medical records confirming an asbestos-related diagnosis are a foundational element of any legal claim.

If you or a family member worked with or around Young pipe insulation and has since been diagnosed with mesothelioma, asbestosis, asbestos-related lung cancer, or pleural disease, the following information is relevant to understanding your options:

  • Young does not appear to operate an asbestos bankruptcy trust fund. This means claims are generally not pursued through a formal trust claim submission process in the way they are for companies such as Johns-Manville (Manville Personal Injury Settlement Trust) or Armstrong World Industries.

  • Civil litigation may be available. According to asbestos litigation records, Young has been named as a defendant in personal injury cases. An asbestos attorney can evaluate whether the company’s current legal and corporate status supports an active claim and in which venues such claims have been pursued.

  • Other trust fund claims may run parallel. Workers exposed to Young pipe insulation were often exposed to asbestos-containing products from multiple manufacturers on the same jobsites. Claims against separately funded trusts — covering other manufacturers whose products were present — may be available simultaneously with any claim involving Young.

  • Statutes of limitations apply. Deadlines for filing asbestos-related claims are governed by state law and typically run from the date of diagnosis rather than the date of exposure. Prompt consultation with an attorney experienced in asbestos litigation is strongly recommended.

  • Secondary exposure claims are recognized. Family members who were exposed to asbestos dust brought home on a worker’s clothing or body may have independent legal claims depending on their diagnosis and applicable law.

Workers, survivors, and families researching Young pipe insulation exposure history are encouraged to consult with an asbestos litigation attorney to evaluate the full scope of available claims based on their specific exposure and medical records.